Latest News
Featured News
Select the category
38th Annual Meeting of the Society for Immunotherapy of Cancer (SITC), 1-5 November 2023 in San Diego, CA, USA
Scancell announces late-breaking abstract presenting positive data from the first stage in its Phase 2 SCOPE trial
Preliminary Results for the year ended 30 April 2023
Interim Report 31st October 2023
Vaccination with post-translational modified, homocitrullinated peptides induces CD8 T-cell responses that mediate antitumor immunity
Update on Final Results
Scancell to present at the 2023 World Vaccine Congress Europe
Block Listing Six Monthly Return
Change of Date for Final Results and Investor Presentation
Notice of Final Results and Investor Presentation
Seventh International Cancer Immunotherapy Conference (CICON23), Milan, September 2023
Scancell announces positive data from the first stage in its Phase 2 SCOPE trial with SCIB1 cancer vaccine delivered by needle free injection for advanced melanoma
No results found.
JOIN OUR MAILING LIST
Sign up for news updates to stay up to date with Scancell.